OncoVista Financial Statements From 2010 to 2026
| OVITDelisted Stock | USD 0.0001 0.00 0.00% |
Check OncoVista Innovative financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OncoVista Innovative's main balance sheet or income statement drivers, such as , as well as many indicators such as . OncoVista financial statements analysis is a perfect complement when working with OncoVista Innovative Valuation or Volatility modules.
OncoVista |
OncoVista Innovative Therapies Company Return On Asset Analysis
OncoVista Innovative's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current OncoVista Innovative Return On Asset | -23.58 |
Most of OncoVista Innovative's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OncoVista Innovative Therapies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, OncoVista Innovative Therapies has a Return On Asset of -23.5768. This is 169.45% higher than that of the Biotechnology sector and about the same as Health Care (which currently averages -23.6) industry. The return on asset for all United States stocks is notably higher than that of the company.
OncoVista Innovative Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining OncoVista Innovative's current stock value. Our valuation model uses many indicators to compare OncoVista Innovative value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OncoVista Innovative competition to find correlations between indicators driving OncoVista Innovative's intrinsic value. More Info.OncoVista Innovative Therapies is considered to be number one stock in return on asset category among its peers. It is regarded fifth in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the OncoVista Innovative's earnings, one of the primary drivers of an investment's value.About OncoVista Innovative Financial Statements
OncoVista Innovative shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although OncoVista Innovative investors may analyze each financial statement separately, they are all interrelated. The changes in OncoVista Innovative's assets and liabilities, for example, are also reflected in the revenues and expenses on on OncoVista Innovative's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
OncoVista Innovative Therapies, Inc., a biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers. The company was founded in 2004 and is based in San Antonio, Texas. ONCOVISTA INNOVATIVE operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in OncoVista Pink Sheet
If you are still planning to invest in OncoVista Innovative check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoVista Innovative's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| CEOs Directory Screen CEOs from public companies around the world |